Get the Stockscreener App
0.00
100.00%
-5.62
After Hours:
6.18
6.18
+
Applied Dna Sciences Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$5.62
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$5.51M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
0.00
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$190.80
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.00 | 5.51M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
What is the fair value estimate for Applied DNA Sciences Inc. (UDJ1) stock in 2025Weekly Stock Report & Safe Capital Growth Trade Ideas - Newser
How Applied DNA Sciences Inc. (UDJ1) stock gains from tech spendingQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Is Applied DNA Sciences Inc. (UDJ1) stock attractive for dividend growth2025 Retail Activity & Long-Term Growth Stock Strategies - Newser
Can Applied DNA Sciences Inc. (UDJ1) stock expand revenue streamsQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
Will Applied DNA Sciences Inc. (UDJ1) stock test record highs in 2025Earnings Trend Report & Daily Oversold Stock Bounce Ideas - Newser
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - Courier & Press
Is Applied DNA Sciences Inc. (UDJ1) stock a buy for dividend portfoliosJobs Report & Weekly Breakout Opportunity Watchlist - Newser
Can Applied DNA Sciences Inc. (UDJ1) stock resist broad market declines2025 Retail Activity & High Return Stock Watch Alerts - Newser
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Newport Daily News
BNB Plus Corp.Common Stock (Nasdaq:BNBX) Stock Quote - Markets Financial Content
Applied DNA Sciences Inc. Announces Executive Changes, February 15, 2015 - MarketScreener
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Livingston Daily
Will Applied DNA Sciences Inc. (UDJ1) stock return to pre crash levels - newser.com
Can Applied DNA Sciences Inc. (UDJ1) stock retain market dominancePortfolio Gains Report & Verified High Yield Trade Plans - newser.com
Will Applied DNA Sciences Inc. stock continue upward momentum - newser.com
Why Applied DNA Sciences Inc. (UDJ1) stock could be top winnerJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Why Applied DNA Sciences Inc. stock could rally in 2025Market Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How Applied DNA Sciences Inc. (UDJ1) stock stacks up against competitorsQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com
Why Applied DNA Sciences Inc. (UDJ1) stock is favored by hedge fundsIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Is Applied DNA Sciences Inc. stock overvalued by current metricsJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Applied DNA Sciences : Reminds Shareholders to Vote Ahead of Special Meeting on February 14 - MarketScreener
Why PHINIA Inc. stock attracts strong analyst attention - newser.com
[Form 3] APPLIED DNA SCIENCES INC Initial Statement of Beneficial Ownership - Stock Titan
Real time breakdown of Applied DNA Sciences Inc. stock performanceProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
Is Applied DNA Sciences Inc. stock a safe buy before earningsJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Will Applied DNA Sciences Inc. stock reach Wall Street targetsJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):